SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-22-262970
Filing Date
2022-10-14
Accepted
2022-10-14 16:24:12
Documents
13
Period of Report
2022-10-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A d387013dpre14a.htm PRE 14A 407403
2 GRAPHIC g387013g03y77.jpg GRAPHIC 38534
3 GRAPHIC g387013g05k11.jpg GRAPHIC 26861
4 GRAPHIC g387013snap10.jpg GRAPHIC 1756
5 GRAPHIC g387013snap11.jpg GRAPHIC 1746
6 GRAPHIC g387013snap12a.jpg GRAPHIC 12340
7 GRAPHIC g387013snap13.jpg GRAPHIC 962
8 GRAPHIC g387013snap3.jpg GRAPHIC 2866
9 GRAPHIC g387013snap5.jpg GRAPHIC 1214
10 GRAPHIC g387013snap6.jpg GRAPHIC 1750
11 GRAPHIC g387013snap7a.jpg GRAPHIC 16104
12 GRAPHIC g387013snap8.jpg GRAPHIC 1197
13 GRAPHIC g387013snapp111.jpg GRAPHIC 10130
  Complete submission text file 0001193125-22-262970.txt   559244
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: PRE 14A | Act: 34 | File No.: 001-39267 | Film No.: 221311589
SIC: 2834 Pharmaceutical Preparations